ConductScience.org, home

Paper41892479

Molecular Characterization of Colistin-Resistant Clinical Acinetobacter baumannii from Northern Greece: Phenotypic Colistin Susceptibility and lpx/pmrCAB Mutational Profiles.

Karakalpakidis D and 7 others. Antibiotics (Basel), 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Molecular Characterization of Colistin-Resistant Clinical Acinetobacter baumannii from Northern Greece: Phenotypic Colistin Susceptibility and lpx/pmrCAB Mutational Profiles. Papers, record 41892479. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41892479

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular Characterization of Colistin-Resistant Clinical Acinetobacter baumannii from Northern Greece: Phenotypic Colistin Susceptibility and lpx/pmrCAB Mutational Profiles.
PubMed
Journal
Antibiotics (Basel)
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Karakalpakidis DDimitrioshttps://orcid.org/0009-0006-6994-0828
2Tsitlakidou MEMichaela-Eftychia
3Paraskeva MMichalishttps://orcid.org/0009-0006-9508-0737
4Mavidi MNMaria Nikoleta
5Marinou MMaria
6Procter KKassandrahttps://orcid.org/0009-0004-5413-3287
7Beloukas AApostoloshttps://orcid.org/0000-0001-5639-0528
8Kottaridi CChristinehttps://orcid.org/0000-0003-0979-3871

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129914966Colistin Heteroresistance and Involvement of the PmrAB Regulatory System in Acinetobacter baumannii.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29914966PubMed
240872240When the Last Line Fails: Characterization of Colistin-Resistant Acinetobacter baumannii Reveals High Virulence and Limited Clonal Dissemination in Greek Hospitals.Pathogens2025https://conductscience.org/library/papers/40872240PubMed
323587960RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23587960PubMed
433466515Susceptibility Testing of Colistin for Acinetobacter baumannii: How Far Are We from the Truth?Antibiotics (Basel)2021https://conductscience.org/library/papers/33466515PubMed
538214512Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates.Microbiol Spectr2024https://conductscience.org/library/papers/38214512PubMed
635065702Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.Lancet2022https://conductscience.org/library/papers/35065702PubMed
733007498PmrB mutations including a novel 10-amino acid repeat sequence insertion associated with low-level colistin resistance in carbapenem-resistant Acinetobacter baumannii.Infect Genet Evol2020https://conductscience.org/library/papers/33007498PubMed
832677578A systematic review of implications, mechanisms, and stability of in vivo emergent resistance to colistin and tigecycline in Acinetobacter baumannii.J Chemother2021https://conductscience.org/library/papers/32677578PubMed
936978383Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology.Antibiotics (Basel)2023https://conductscience.org/library/papers/36978383PubMed
1039908088Whole-genome sequencing of Acinetobacter baumannii clinical isolates from a tertiary hospital in Terengganu, Malaysia (2011-2020), revealed the predominance of the Global Clone 2 lineage.Microb Genom2025https://conductscience.org/library/papers/39908088PubMed
1116145081Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii.J Clin Microbiol2005https://conductscience.org/library/papers/16145081PubMed
1224189257Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24189257PubMed
1326653099Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data.BMC Infect Dis2015https://conductscience.org/library/papers/26653099PubMed
1432762604Colistin Resistance in Environmental Isolates of Acinetobacter baumannii.Microb Drug Resist2021https://conductscience.org/library/papers/32762604PubMed
1537600939Retained colistin susceptibility in clinical Acinetobacter baumannii isolates with multiple mutations in pmrCAB and lpxACD operons.Front Cell Infect Microbiol2023https://conductscience.org/library/papers/37600939PubMed
1633364795Molecular Characterization of Carbapenem/Colistin-Resistant Acinetobacter baumannii Clinical Isolates from Egypt by Whole-Genome Sequencing.Infect Drug Resist2020https://conductscience.org/library/papers/33364795PubMed
1730541939Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.J Clin Microbiol2019https://conductscience.org/library/papers/30541939PubMed
1829326661En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach.Front Microbiol2017https://conductscience.org/library/papers/29326661PubMed
1932411113Population Biology and Epidemiological Studies of Acinetobacter baumannii in the Era of Whole Genome Sequencing: Is the Oxford Scheme Still Appropriate?Front Microbiol2020https://conductscience.org/library/papers/32411113PubMed
2032284036Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019).Emerg Microbes Infect2020https://conductscience.org/library/papers/32284036PubMed

See all 45 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42268331Whole-genome characterization of a colistin-resistant Klebsiella quasipneumoniae subsp. quasipneumoniae isolate from a urinary tract infection in Peshawar, Pakistan.Braz J Microbiol2026https://conductscience.org/library/papers/42268331

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
HSPD13329PubTator's text mininghttps://conductscience.org/library/genes/3329

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41892479

GET https://conductscience.org/api/papers/v1/41892479/references?page=2